Drug Testing Procedure definition

Drug Testing Procedure means the taking of and analyzing bodily fluids or materials for the purpose of detecting the presence of alcohol or drugs;
Sample 1Sample 2Sample 3
Drug Testing Procedure means the drug testing procedure implemented by and/or on behalf of the Company in respect of persons engaged in Works at any of its sites;
Sample 1Sample 2Sample 3
Drug Testing Procedure means the drug testing procedure implemented by and/or on behalf of the Purchaser in respect of persons engaged in the provision of Services at the Delivery Address;
Sample 1Sample 2

Examples of Drug Testing Procedure in a sentence

  • NOTE REGARDING DRUG TESTING: The Greenfield-Central Athletic Department supports and will follow the Random Drug Testing Procedure which is outlined in the Greenfield-Central High School Student Handbook.

  • As per Drug Testing Procedure Form offenders may be required to make a daily phone call to verify if they have a drug screen that day.

  • Arkansas Tech University Drug Testing Procedure Arkansas Tech University will enact a procedure for randomly testing all of its athletes for the use of illegal drugs and substances banned by the NCAA.

  • The parties met and conferred and established an Alcohol and Drug Testing Procedure and said understanding is recorded in a side letter dated March 2, 1993.

  • OHS will coordinate the test according to the For Cause Drug Testing Procedure in Section F below.

  • Section 3 of the volunteer ambulance workers' benefit law is amended by adding a new subdivision 15 to read as follows: 15.

  • All conditions, terms, representations and warranties that are not expressly stated in this Agreement, whether oral or in writing or whether imposed by statute or operation of law or otherwise, including, without limitation, the implied warranty of satisfactory quality and fitness for a particular purpose are hereby excluded.

  • PSC Drug Testing Procedure & RecommendationsPSC requires each student-athlete to sign a drug screening consent form (if the student-athlete is under the age of eighteen, the consent form must also be signed by a parent or guardian).

  • The Contractor shall be entitled, on behalf of the relevant employee, agent, representative or sub-contractor, to challenge the results of any Drug Testing Procedure undertaken by and/or on behalf of the Company pursuant to Condition 22.3 immediately upon receipt of the results of the Drug Testing Procedure.

  • The Contractor shall procure that, upon request from the Company, such of its employees, agents, representatives and/or sub-contractors as may be required by the Company shall attend at a site (at a time and date designated by the Company) for the purposes of such employees, agents, representatives and/or sub-contractors undertaking the Drug Testing Procedure.

Related to Drug Testing Procedure

  • Staff Vetting Procedure means the Authority’s procedures for the vetting of personnel and as advised to the Contractor by the Authority.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Manufacturing Process means any process for—

  • Staff Vetting Procedures means the Authority’s procedures for the vetting of personnel and as advised to the Contractor by the Authority.

  • Standard operating procedure means a formal written procedure offi- cially adopted by the plant owner or operator and available on a routine basis to those persons responsible for carrying out the procedure.

  • technical specification means, with respect to any Software, the document setting forth the technical specifications for such Software and included in the Statement of Work.

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Product Specification means a product specification for a Medical Device set out in Schedule 2;

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.

  • Web Site Accessibility Standards/Specifications means standards contained in Title 1 Texas Administrative Code Chapter 206.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Web Site Accessibility Standards/Specifications means standards contained in Title 1 Texas Administrative Code Chapter 206.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Technical Specifications means the detailed requirements for the Work furnished by the Architect and set forth in Book 3 of the Contract Documents.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Standard Operating Procedures or “SOP” means the procedures as specified in the Annexes or Attachments to the relevant Schedules;

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • cGMP means current Good Manufacturing Practice as set forth in the United States Federal Food, Drug, and Cosmetic Act, as amended, and includes all rules and regulations promulgated by the FDA thereunder.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).